Key facts
- This page summarizes Devdatt Kurdikar's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 02 Oct 2025, 17:19.
Devdatt Kurdikar - 30 Sep 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Role
- Director
- Signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Devdatt Kuridkar (power of attorney previously filed)
- Issuer symbol
- ZBH
- Transactions as of
- 30 Sep 2025
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 02 Oct 2025, 17:19:30 UTC
- Previous filing
- 02 Jul 2025
- Next filing
- 01 Dec 2025
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Devdatt Kurdikar filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 02 Oct 2025.
Change
- Previous filing in this sequence was filed on 02 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001910621
Primary reporting owner
Kurdikar Devdatt
- Relationship
- Director
- Address
- 345 E. MAIN STREET, WARSAW
- Signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Devdatt Kuridkar (power of attorney previously filed)
- Signature date
- 02 Oct 2025
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
ZBH
transaction
Derivative
Phantom Stock Units
Award
- Transaction value
- $0
- Shares
- +140
- Change %
- +9.5%
- Price
- $0.000000
- Shares after
- 1,614
- Date
- 30 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 140
- Exercise price
- $98.10
- Footnotes
- F1, F2, F3, F4
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
| F2 | The Conversion or Exercise Price of Derivative Security is 1-for-1. |
| F3 | The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. |
| F4 | Includes 3.428 phantom stock units accrued on July 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |